Drug intelligence / Profile preview

Huzhang Jiedu Keli

Development stage
Unknown
Lead developer
Shanghai Municipal Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Huzhang Jiedu Keli (虎杖解毒颗粒) is a Traditional Chinese Medicine (TCM) formulation primarily composed of *Polygonum cuspidatum* (Huzhang). It is recognized for its potent anti-inflammatory and antiviral properties, largely attributed to its high content of resveratrol and polydatin. The drug was notably included in Chinese clinical guidelines as a recommended treatment for COVID-19 to manage inflammatory responses and viral symptoms. Beyond its use in infectious diseases, Huzhang Jiedu Keli has been investigated as an adjuvant therapy in oncology, specifically for its potential to modulate the ecological niche microenvironment in patients with liver metastasis from colorectal cancer. It is typically administered orally in a granule form.

Other names
虎杖解毒颗粒Polygonum Cuspidatum Detoxification GranulesHuzhang Jiedu Granules
02

Targets

NF-κBTNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Huzhang Jiedu Keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huzhang Jiedu Keli.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call